WAK-27602-24932
2 vaccinations
4 coded responses
17 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 666 / KS
- Registered
- 2022-09-05
- Relationship
- Child or adolescent in my care
- Guardian
- 34X-61631-72315
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-29
Dose 1 — Pfizer-BioNTechCo-administered: MMR:Pneumonia:Polio:Rotavirus:Tetanus
-
2022-09-05
Registered in v-safe
- 2022-09-05
- 2022-09-12
-
2022-09-19
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-19
-
2022-09-20
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-09-21
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Faeces soft — Feeling: GoodFree text: No diarrhea, but is softer stoolsMedDRA releases: 2024-11 · check-in free text available
- 2022-09-22
- 2022-09-23
-
2022-09-24
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Faeces soft — Feeling: GoodFree text: Soft stoolsMedDRA releases: 2024-11 · check-in free text available
- 2022-09-25
- 2022-09-26
- 2022-10-03
- 2022-10-11
- 2022-10-19
-
2022-10-24
Survey response — day 35, dose 2, under 3MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold- not RSV. Lungs sounded good, has runny nose, cough, and probably sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-10-24
Report sent to call center — day 35, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-25
- 2022-10-31
-
2022-12-19
Survey response — 3 months, dose 2, under 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Had covid first of monthMedDRA releases: 2024-11 · check-in free text available
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-29 | Pfizer-BioNTech | MMR:Pneumonia:Polio:Rotavirus:Tetanus |
| 2 | 2022-09-19 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-24 | Unsuccessful |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): No diarrhea, but is softer stools
Systemic reaction (other): Soft stools
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Cold- not RSV. Lungs sounded good, has runny nose, cough, and probably sore throat
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Had covid first of month
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Faeces soft | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release